Literature DB >> 10420216

Electronic monitoring of treatment compliance in patching for amblyopia.

H J Simonsz1, J R Polling, R Voorn, J van Leeuwen, H Meester, C Romijn, B G Dijkstra.   

Abstract

We developed a coinsized occlusion dose monitor (ODM) to measure compliance with patch-wearing during the treatment of amblyopia objectively. It measures the temperature difference between the front and back of the ODM every 2-5 minutes by means of two thermistors. The data is stored in EEPROM memory and read out after recording for a week by connecting it to a PC. The ODM measures 35x23x4 mm and weighs 6 g. The back of the ODM is glued to the front of the amblyopia patch with double-sided Scotch tape. When the patch with the ODM is on the eye, the temperature at the back of the ODM is higher than at the front. Compliance is being studied in children taking part in a large amblyopia cohort study. The parents were instructed during home visits every three months to put the ODM on the patch. After a week, the ODM was collected and read out. Although the parents knew that a recording was being made, compliance was mediocre in many cases. Children were patched infrequently, for 5 minutes only, for long periods on the last days of the recording, at night, etc. Diaries detailing patch time were unreliable.

Entities:  

Mesh:

Year:  1999        PMID: 10420216     DOI: 10.1076/stra.7.2.113.645

Source DB:  PubMed          Journal:  Strabismus        ISSN: 0927-3972


  19 in total

1.  Differences in the management of amblyopia between European countries.

Authors:  J H Y Tan; J R Thompson; I Gottlob
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  A randomised controlled trial of written information.

Authors:  P Lempert
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

3.  A randomised controlled trial of written information.

Authors:  P Lempert
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

4.  Electronic recording of occlusion treatment for amblyopia: potential of the new technology.

Authors:  Yaroslava Chopovska; Sjoukje E Loudon; Licia Cirina; Alina Zubcov; Huibert J Simonsz; Marc Lüchtenberg; Maria Fronius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

5.  Mehdi-ODM; a modified digital monitoring of the occlusion therapy for amblyopia.

Authors:  Amir Hasan Gharebaghi; Fatemeh Heidary; Reza Gharebaghi; Roghayeh Heidary
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-18       Impact factor: 3.117

6.  Comparison between over-glasses patching and adhesive patching for children with moderate amblyopia: a prospective randomized clinical trial.

Authors:  Su Jin Kim; Hyeshin Jeon; Jae Ho Jung; Kwang Min Lee; Hee Young Choi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-12-04       Impact factor: 3.117

Review 7.  [Treatment monitoring and innovations in amblyopia treatment].

Authors:  Kai Januschowski; Caroline Emmerich; Annegret Abaza; Henrike Julich-Haertel; Annekatrin Rickmann
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

8.  Effect of age on response to amblyopia treatment in children.

Authors:  Jonathan M Holmes; Elizabeth L Lazar; B Michele Melia; William F Astle; Linda R Dagi; Sean P Donahue; Marcela G Frazier; Richard W Hertle; Michael X Repka; Graham E Quinn; Katherine K Weise
Journal:  Arch Ophthalmol       Date:  2011-07-11

9.  A morphological study of amblyopic eyes in children failing to achieve normal visual acuity after electronically monitored long-term occlusion treatment.

Authors:  Claudia Kuhli-Hattenbach; Michael Janusz Koss; Thomas Kohnen; Maria Fronius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-23       Impact factor: 3.117

10.  Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).

Authors:  C E Stewart; A R Fielder; D A Stephens; M J Moseley
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.